| 5-FU | 5-fluorouracil |
| ADAM17 | Adisintegrin and metalloproteinase 17 |
| ALD | Alcoholic liver disease |
| ALC | Alcoholic liver cirrhosis |
| APC | Antigen presenting cells |
| ARG1 | Arginase 1 |
| ATRA | All-trans retinoic acid |
| CCL | Chemokine (C-C motif) ligand |
| CCR | CC motif chemokine receptors |
| CIK | Cytokine-induced killer |
| COX2 | Cyclooxygenase 2 |
| CSF1/M-CSF | Colony-stimulating factor 1 |
| CSF1R | Colony-stimulating factor 1 receptor |
| CXCL | C-X-C motif ligand |
| DCs | Dendritic cells |
| eMDSCs | Early MDSCs |
| ENTPD2 | Ectonucleoside triphosphate diphosphohydrolase 2 |
| Gem | Gemcitabine |
| GMP | Gemcitabine monophosphate |
| HAIC | Hepatic arterial infusion chemotherapy |
| HBV | Hepatitis B virus |
| HCC | Hepatocellular carcinoma |
| HCV | Hepatitis C virus |
| HDACIs | Histone deacetylase inhibitors |
| HSCs | Hematopoietic stem cells |
| ICIs | Immune-checkpoint inhibitors |
| IDO | Indoleamine2,3-dioxygenase1 |
| IL | Multiple interleukins |
| IMCs | Immature myeloid cells |
| LCP | Lipid-coated calcium phosphate |
| LN | L-selectin lymph node |
| LOX-1 | Lectin-type oxidized LDL receptor 1 |
| MDSCs | Myeloid-derived suppressor cells |
| M-MDSCs | Monocytic MDSCs |
| MPO | Myeloperoxidase |
| NAFLD | Non-alcoholic fatty liver disease |
| NO | Nitric oxide |
| NOX2 | NADPH oxidase |
| PDE5 | Phosphodiesterase 5 |
| PGE2 | Prostaglandin E2 |
| PMN-MDSCs | Polymorphonuclear MDSCs |
| RIPK3 | Receptor-interacting protein kinase 3 |
| RNS | Reactive nitrogen species |
| ROS | Reactive oxygen |
| TAFs | Tumor-associated fibroblasts |
| TAM2 | M2-polarized tumor-associated macrophages |
| TLR2 | Toll-like receptors 2 |
| TIM3 | T-cells immunoglobulin and mucin domain-containing protein 3 |
| TIME | Tumor immune microenvironment |
| TKIs | Tyrosine kinase inhibitors |
| TNF-a | Tumor necrosis factor-a |
| TRAIL-Rs | TNF-related apoptosis-induced ligand receptors |
| Tregs | Regulatory T cells |